Estimating Risk of Respiratory Infections Attributable to CFTR Heterozygosity
Recruiting
Observational Study
Carrier State
Respiratory Infections
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 160 (estimated)
- Sponsor
- Philip Polgreen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A research team member will brush the inferior surface of the subjects' middle turbinate (nasal cavity) using a cytology brush to obtain the cells needed to perform our functional respiratory assays.
An individual trained in phlebotomy will draw one 3 ml lavender top tube of blood to test c-reactive protein, calprotectin, and lactoferrin. They will also draw a 5 ml gold top serum separator tube o…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
CF Carrier Inclusion Criteria:
* Previously tested and shown to be a CF carrier
* English-speaking
Control Group Inclusion Criteria:
* Previously tested and shown to not be a CF carrier or CF patient
* English-speaking
Exclusion Criteria:
* Currently sick with a respiratory infection
* Prisoner…
Contacts